Q2 2026 net sales fell organically 4%, with reported net sales down 6% to SEK 14,383m (SEK 15,277), including a -2% FX impact. Operating income declined to SEK 1,600m from SEK 2,063, with operating margin contracting to 11.1% from 13.5%. Items affecting comparability were SEK -349m, tied mainly to cost-saving execution and a write-down related to the Brastad factory.
This reads like a regional mix problem rather than a broad demand collapse. The key mechanism is fixed-cost absorption: when Europe softens faster than the cost base can flex, margin compresses even if North America is still growing, and the factory write-down suggests management is acknowledging excess capacity rather than just temporary volatility. That usually means the next leg is either deeper restructuring or a slower-than-expected recovery in operating leverage.
For peers, the second-order effect is that U.S.-centric competitors can use this window to take share in North America while Europe-heavy players are forced into price discipline and smaller production runs. Suppliers tied to the affected European footprint—industrial services, transport, maintenance, and local subcontractors—face a quieter order environment if management continues to rationalize assets. The market should be careful not to treat cost-savings as a clean offset: savings often arrive with a lag, while volume weakness hits margins immediately.
The contrarian view is that the charge may be front-loaded and the underlying business may already be bottoming if North America holds. If the next quarter shows Europe stabilizing and no further asset impairments, the current reset could look like a one-time clean-up rather than a multi-quarter deterioration. The bearish case is invalidated quickly if Europe organic trends improve or if management refrains from signaling additional restructuring, because then the market may re-rate the name as a cyclical trough story instead of a structural margin issue.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.35